DHCR – Advances in the clinical development of PI3K inhibitors

January 25, 2023DHCR

In tumors with mutational activation of both PI3K/AKT and MEK/ERK pathways, inhibition of either pathway alone has minor or negligible effects on cell survival and tumor growth [31]

by euromed2016

In tumors with mutational activation of both PI3K/AKT and MEK/ERK pathways, inhibition of either pathway alone has minor or negligible effects on cell survival and…

April 23, 2022DHCR

CII Immunized and non-immunized mice (control) were orally fed 1010O157:H7 and shedding was monitored in the feces for a month All contaminated eyes in Non-immunized control guinea pig made moderate to serious conjunctivitis with hyperemia, discharge and edema, showed complete purulent keratoconjuctivitis (score 3)

by euromed2016

CII Immunized and non-immunized mice (control) were orally fed 1010O157:H7 and shedding was monitored in the feces for a month All contaminated eyes in Non-immunized…

March 21, 2022DHCR

A

by euromed2016

A. of cdk4 in epithelial cells in the lack of exogenous development factors. Adhesion of epithelial cells towards the ECM didn’t induce degradation PF 750…

February 13, 2022DHCR

[17] reported that SAHA exerted significant inhibitory efficiency against cellular survival, proliferation, migration and vasculogenic mimicry of pancreatic cancer cells

by euromed2016

[17] reported that SAHA exerted significant inhibitory efficiency against cellular survival, proliferation, migration and vasculogenic mimicry of pancreatic cancer cells. bottom of the catalytic cavity,…

November 5, 2021DHCR

HER2 amplification is significantly within breasts cancer tumor 39 also, with the price around 15-30%, and can be within 10-30% of gastric or gastroesophageal malignancies 40

by euromed2016

HER2 amplification is significantly within breasts cancer tumor 39 also, with the price around 15-30%, and can be within 10-30% of gastric or gastroesophageal malignancies…